Low blood-brain barrier permeability to azidothymidine (AZT), 3TC™ and thymidine in the rat

被引:41
作者
Wu, DA
Clement, JG
Pardridge, WM [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] BioChem Therapeut Inc, Laval, PQ H7V 4A7, Canada
关键词
zidovudine; lamivudine; thymidine; lipid solubility; blood-brain barrier;
D O I
10.1016/S0006-8993(98)00139-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) permeability to [H-3]-azidodeoxythymidine (AZT), deoxythiacytidine (3TC(TM)), and thymidine was studied using both an intravenous injection/external organ (IV/EO) method and an internal carotid artery perfusion (ICAP) technique in parallel with [C-14]-sucrose as a plasma volume marker. The brain volumes of distribution (V-D) of the three compounds approximated that of sucrose with either method. Although the lipid solubility of AZT, as determined by the 1-octanol/buffer partition coefficient (P), was 16-fold higher than that of thymidine, the BBB permeability-surface area (PS) products were almost identical, consistent with preferential efflux of AZT from brain to blood. (C) 1998 Published by Elsevier Science B.V.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 20 条
[1]  
AHMED AE, 1991, J PHARMACOL EXP THER, V257, P479
[2]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[3]   INDEPENDENT BLOOD-BRAIN-BARRIER TRANSPORT-SYSTEMS FOR NUCLEIC-ACID PRECURSORS [J].
CORNFORD, EM ;
OLDENDORF, WH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 394 (02) :211-219
[4]  
DYKSTRA KH, 1993, J PHARMACOL EXP THER, V267, P1227
[5]   ISOLATION OF HTLV-III FROM CEREBROSPINAL-FLUID AND NEURAL TISSUES OF PATIENTS WITH NEUROLOGIC SYNDROMES RELATED TO THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
HO, DD ;
ROTA, TR ;
SCHOOLEY, RT ;
KAPLAN, JC ;
ALLAN, JD ;
GROOPMAN, JE ;
RESNICK, L ;
FELSENSTEIN, D ;
ANDREWS, CA ;
HIRSCH, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) :1493-1497
[6]   IN-VITRO AND IN-VIVO TRANSPORT OF ZIDOVUDINE (AZT) ACROSS THE BLOOD-BRAIN-BARRIER AND THE EFFECT OF TRANSPORT INHIBITORS [J].
MASEREEUW, R ;
JAEHDE, U ;
LANGEMEIJER, MWE ;
DEBOER, AG ;
BREIMER, DD .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :324-330
[7]   HIV-1, MACROPHAGES, GLIAL-CELLS, AND CYTOKINES IN AIDS NERVOUS-SYSTEM DISEASE [J].
MERRILL, JE ;
CHEN, ISY .
FASEB JOURNAL, 1991, 5 (10) :2391-2397
[8]   HIGH-LEVELS OF UNINTEGRATED HIV-1 DNA IN BRAIN-TISSUE OF AIDS DEMENTIA PATIENTS [J].
PANG, S ;
KOYANAGI, Y ;
MILES, S ;
WILEY, C ;
VINTERS, HV ;
CHEN, ISY .
NATURE, 1990, 343 (6253) :85-89
[9]  
PARDRIDGE WM, 1994, J PHARMACOL EXP THER, V268, P14
[10]   TRANSPORT OF STEROID-HORMONES THROUGH THE RAT BLOOD-BRAIN-BARRIER - PRIMARY ROLE OF ALBUMIN-BOUND HORMONE [J].
PARDRIDGE, WM ;
MIETUS, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (01) :145-154